Home » Dynavax Issued Landmark Patent Covering Second-Generation TLR9 Agonists
Dynavax Issued Landmark Patent Covering Second-Generation TLR9 Agonists
Dynavax Technologies announced that the U.S. Patent Office has issued the company a broad composition of matter patent covering the company’s proprietary second-generation TLR9 agonists.
Yahoo Finance
Upcoming Events
-
23Apr
-
25Apr
-
07May
-
14May
-
30May